Health Care & Life Sciences » Biotechnology | Osiris Therapeutics Inc.

Osiris Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2017
Cash & Short Term Investments
34,092.00
59,010.00
50,104.00
27,888.00
Total Accounts Receivable
3,063.00
22,828.00
23,454.00
30,841.00
Inventories
1,278.00
1,929.00
9,824.00
11,278.00
Other Current Assets
603.00
446.00
2,894.00
2,920.00
Total Current Assets
39,036.00
84,213.00
86,276.00
72,927.00
Net Property, Plant & Equipment
2,111.00
1,896.00
2,079.00
3,587.00
Total Investments and Advances
317.00
243.00
-
-
Other Assets
-
-
95.00
1,608.00
Total Assets
41,464.00
92,201.00
88,450.00
78,122.00
ST Debt & Current Portion LT Debt
44.00
45.00
45.00
-
Accounts Payable
4,999.00
4,842.00
7,468.00
5,269.00
Income Tax Payable
-
5,849.00
-
-
Other Current Liabilities
0.00
57.00
1,667.00
29,833.00
Total Current Liabilities
5,043.00
10,793.00
9,180.00
35,102.00
Long-Term Debt
162.00
-
-
-
Deferred Taxes
-
5,849.00
-
-
Other Liabilities
369.00
355.00
3,589.00
1,626.00
Total Liabilities
5,574.00
11,148.00
12,769.00
36,728.00
Common Equity (Total)
35,890.00
81,053.00
75,681.00
41,394.00
Total Shareholders' Equity
35,890.00
81,053.00
75,681.00
41,394.00
Total Equity
35,890.00
81,053.00
75,681.00
41,394.00
Liabilities & Shareholders' Equity
41,464.00
92,201.00
88,450.00
78,122.00

About Osiris Therapeutics

View Profile
Address
7015 Albert Einstein Drive
Columbia Maryland 21046
United States
Employees -
Website http://www.osiris.com
Updated 09/14/2018
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. The company was founded by Peter A.